Clinical Trial

hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety and efficacy of hUC-MSCs-Exos in the treatment of ulcerative colitis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-28.
Trial Details
NCT Number NCT06853522
Lead Sponsor Shanghai East Hospital
Conditions Ulcerative Colitis (UC)
Enrollment 40 participants
Start Date 2025-05-30
Primary Completion 2027-04-04 (estimated)
Study Completion 2028-04-04 (estimated)
Updated on ClinicalTrials.gov 2025-04-27